Table 1.
Overall N=426 | |
---|---|
Clinical Characteristics | |
Male | 237 (56%) |
Term (>36 weeks gestation) | 373 (88%) |
Admission to the study center at <24 hours of age | 222 (52%) |
Medical Comorbidities | |
Congenital cardiac disease | 60 (14%) |
ECMO | 27 (6%) |
Dialysis | 6 (1%) |
Congenital diaphragmatic hernia | 4 (1%) |
Indication for cEEG Monitoring | |
Clinical event suspicious for seizure | 267 (63%) |
Encephalopathy | 82 (19%) |
Clinical event and encephalopathy | 62 (15%) |
Other | 15 (4%) |
Seizure Etiology | |
Hypoxic ischemic encephalopathy | 163 (38%) |
Ischemic stroke | 75 (18%) |
Intracranial hemorrhage | 49 (12%) |
Epileptic encephalopathy/Genetic epilepsy | 24 (6%) |
Intracranial infection | 19 (4%) |
Brain Malformation | 18 (4%) |
Transient metabolic (hypoglycemia or electrolyte disturbance) | 16 (4%) |
Inborn error of metabolism | 13 (3%) |
Benign familial neonatal epilepsy | 11 (3%) |
Other/Unknown | 38 (9%) |
Short Term Outcomes | |
Death or transfer to hospice | 72 17%) |
Abnormal mental status, tone or reflexes among survivors at discharge/transfer | 173 (49%) |
Length of hospital stay among survivors discharged home, days | 14 (10, 28) |
Data are presented as N(%), median(interquartile range)
ECMO extracorporeal membrane oxygenation, cEEG continuous video-EEG monitoring